AORT · Artivion, Inc. · Executive Compensation
$22.82
-0.04 (-0.17%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$1.10B
Shares
48.76M
Volume · Sep 30
501.4K
Avg daily vol (3M)
647.27K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| J. Patrick Mackin | Chairman, President and Chief Executive Officer | $6,883,108 |
| Lance Berry | CFO | $2,977,091 |
| Lance A. Berry | Executive Vice President, Chief Operating Officer, Chief Financial Officer, and Treasurer | $2,977,091 |
| John E. Davis | Senior Vice President, Chief Commercial Officer | $1,958,047 |
| Jean F. Holloway | Senior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer | $1,909,597 |
| Marshall S. Stanton | Senior Vice President, Clinical Research and Chief Medical Officer | $1,660,393 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| J. Patrick Mackin | Chairman, President and Chief Executive Officer | $5,511,940 |
| Lance Berry | CFO | $2,574,033 |
| Lance A. Berry | Executive Vice President, Chief Operating Officer, Chief Financial Officer, and Treasurer | $2,574,033 |
| Jean F. Holloway | Senior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer | $1,515,413 |
| John E. Davis | Senior Vice President, Chief Commercial Officer | $1,491,482 |
| Marshall S. Stanton | Senior Vice President, Clinical Research and Chief Medical Officer | $1,293,613 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| J. Patrick Mackin | Chairman, President and Chief Executive Officer | $3,176,413 |
| Lance A | Berry, Executive Vice President, Chief Financial Officer | $1,638,357 |
| Lance Berry | CFO | $1,638,357 |
| Lance A. Berry | Executive Vice President, Chief Financial Officer | $1,638,357 |
| D. Ashley Lee | Executive Vice President, Chief Financial Officer | $1,375,917 |
| Amy D. Horton | Vice President, Chief Accounting Officer | $1,061,924 |
| Jean F. Holloway | Senior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer | $993,719 |
| John E. Davis | Senior Vice President, Chief Commercial Officer | $953,405 |
| Marshall S. Stanton | Senior Vice President, Clinical Research and Chief Medical Officer | $942,000 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| J. Patrick Mackin | Chairman, President and Chief Executive Officer | $7,216,340 |
| D. Ashley Lee | Executive Vice President, Chief Financial Officer | $2,330,212 |
| Jean F. Holloway | Senior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer | $1,666,379 |
| John E. Davis | Senior Vice President, Chief Commercial Officer | $1,628,590 |
| Marshall S. Stanton | Senior Vice President, Clinical Research and Chief Medical Officer | $1,609,031 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| J. Patrick Mackin | Chairman, President and Chief Executive Officer | $4,628,566 |
| Jean F. Holloway | Senior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer | $1,577,933 |
| D. Ashley Lee | Executive Vice President, Chief Financial Officer | $1,502,053 |
| John E. Davis | Senior Vice President, Chief Commercial Officer | $1,126,632 |
| Marshall S. Stanton | Senior Vice President, Clinical Research and Chief Medical Officer | $947,228 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| J. Patrick Mackin | Chairman, President and Chief Executive Officer | $3,415,458 |
| D. Ashley Lee | Executive Vice President, Chief Financial Officer, and Chief Operating Officer | $1,183,874 |
| Jean F. Holloway | Senior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer | $961,742 |
| John E. Davis | Senior Vice President, Global Sales and Marketing | $900,301 |
| Michael S. Simpson | Senior Vice President, Regulatory Affairs and Quality Assurance | $862,437 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| J. Patrick Mackin | Chairman, President and Chief Executive Officer | $6,453,541 |
| D. Ashley Lee | Executive Vice President, Chief Financial Officer, and Chief Operating Officer | $1,737,648 |
| Jean F. Holloway | Senior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer | $1,391,065 |
| Michael S. Simpson | Senior Vice President, Regulatory Affairs and Quality Assurance | $1,371,193 |
| John E. Davis | Senior Vice President, Global Sales and Marketing | $1,355,191 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| J. Patrick Mackin | Chairman, President and Chief Executive Officer | $3,231,170 |
| D. Ashley Lee | Executive Vice President, Chief Operating Officer, and Chief Financial Officer | $1,261,670 |
| Jean F. Holloway | Senior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer | $1,031,941 |
| John E. Davis | Senior Vice President, Global Sales and Marketing | $923,369 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| J. Patrick Mackin | Chairman, President and Chief Executive Officer | $2,737,304 |
| D. Ashley Lee | Executive Vice President, Chief Operating Officer, and Chief Financial Officer | $1,134,102 |
| Jean F. Holloway | Senior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer | $893,174 |
| John E. Davis | Senior Vice President, Global Sales and Marketing | $841,036 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Marshall S. Stanton | Senior Vice President, Clinical Research and Chief Medical Officer | Retired | 2025-08-11 |
| Lance A. Berry | Chief Operating Officer | Appointed | 2025-08-11 |
| Lance A. Berry | Chief Financial Officer and Treasurer | Appointed | 2023-12-06 |
| D. Ashley Lee | Executive Vice President, Chief Financial Officer and Treasurer | Retired | 2023-12-06 |
| Elizabeth A. Hoff | director | Appointed | 2022-09-29 |